Tag: heart disease
-
EU-Funded Project to Develop Biomaterials for Stents
Ceram, a materials technology company in Stoke-on-Trent in the U.K., is coordinating a project funded by the European Commission to develop new biocompatible materials suitable for stents that help keep blood vessels open in the heart. The project, known as Rebiostent, is receiving €4.58 million of its €5.87 million ($US 6.19 million of $7.93 million)…
-
Heart Vessel Surgical Glue Shown Effective in Animal Tests
Surgeons and biomedical engineers at Boston Children’s and Brigham and Women’s hospitals and Massachusetts Institute of Technology, developed a non-toxic, biocompatible surgical glue that in tests with pigs patches heart defects, such as those in large blood vessels. The team led by Boston Children’s Pedro del Nido and Jeffrey Karp of Brigham and Women’s Hospital…
-
Patch Finds More Heart Rhythm Problems Than Holter Monitor
Researchers at Scripps Translational Science Institute in La Jolla, California found a small adhesive patch worn over the heart outperformed the conventional Holter monitor in detecting abnormal heart rhythms. The team led by Scripps cardiologist Eric Topol published its findings online in this month’s issue of the American Journal of Medicine. Topol and colleagues tested…
-
Gene Therapy Shows Long-Term Benefit for Heart Failure
A therapy using genes to induce production of an enzyme for heart cells to restore their use of calcium was found to help heart failure patients in a clinical trial reduce their incidents of cardiac problems over a three-year period. Researchers at Mount Sinai Health System in New York, with colleagues from the biotechnology company…
-
Nutritional Labeling Leads to Healthier Restaurant Choices
A study in Philadelphia shows consumers who read nutritional labels on restaurant menus purchase items lower in calories, sodium, and saturated fats than patrons of that restaurant chain overall. The results of the study by researchers at Drexel University, University of Pennsylvania, and Philadelphia’s public health department appear online in yesterday’s advance issue of the…
-
Engineered Tomato Helps Cut Contributor to Clogged Arteries
Researchers at University of California in Los Angeles found feeding a bio-engineered tomato to lab animals cuts their production of a fatty acid believed to contribute to high cholesterol levels. The team led by Alan Fogelman, director of the atherosclerosis research unit at UCLA’s medical school published their findings in the December issue of the…
-
Trial Shows No Benefit from GSK Chronic Heart Disease Drug
The global pharmaceutical company GlaxoSmithKline (GSK) reported today in a late-stage clinical trial its candidate drug darapladib to treat chronic coronary heart disease did not meet its goal of increasing the amount of time between severe heart problems compared to a placebo. The company says some of the trial’s secondary goals related to coronary events…
-
Biosensor Detects Brain-Damaging Proteins in Heart Surgery
Engineers and medical researchers at Johns Hopkins University in Baltimore developed a tiny sensor for technology to detect potential brain damage among patients undergoing heart surgery, particularly children. The team led by Howard Katz, chair of Johns Hopkins’s engineering and materials science department, published its findings in today’s issue of the journal Chemical Science (paid…
-
Strategy Sought to Encourage New Anticoagulant Prescriptions
A new challenge on InnoCentive is looking for new ways to encourage physicians to prescribe anticoagulant drugs other than the commonly used warfarin for decreasing the formation of blood clots in people with atrial fibrillation. The competition has a total purse of $7,500 and a deadline of 27 November 2013. InnoCentive in Waltham, Massachusetts conducts…
-
DNAnexus, Baylor Partner on Large-Scale Genomic Analysis
Genomics and bioinformatics researchers at Baylor College of Medicine in Houston and analytical services company DNAnexus in Mountain View, California are collaborating on large-scale genomic sequencing for research and clinical applications, with a cloud computing platform. The partnership already processed genomic data from more than 14,000 individuals for a genetics analysis on heart disease and…